Medicines

  1. Ketas (ibudilast)
    Ketas (ibudilast)
    by Kyorin Pharmaceuticals Co
    for Amyotrophic Lateral Sclerosis (ALS), Cerebral Infarction
    €469.00
  2. Aimovig (erenumab)
    Aimovig (erenumab)
    by Amgen Inc., Novartis Pharmaceuticals Corporation
    for Migraine
    €694.00
  3. Radicut/Radicava (edaravone)
    Radicut/Radicava (edaravone)
    by Mitsubishi Tanabe Pharma Co., Ltd.
    for Amyotrophic Lateral Sclerosis (ALS), Cerebral Infarction
    €992.00
  4. Edaravone (generic)
    Edaravone (generic)
    by Pfizer Japan Inc.
    for Cerebral Infarction
    €420.00
  5. Venclyxto/Venclexta (venetoclax)
    Venclyxto/Venclexta (venetoclax)
    by AbbVie Ltd
    for Leukemia
    €112.80
  6. Alecensa (alectinib)
    Alecensa (alectinib)
    by Roche Registration GmbH
    for Lung Cancer
    €5,491.50
  7. Alunbrig (brigatinib)
    Alunbrig (brigatinib)
    by ARIAD Pharmaceuticals, Inc.
    for Lung Cancer
    €7,035.00
  8. Austedo (deutetrabenazine)
    Austedo (deutetrabenazine)
    by Teva Pharmaceuticals
    for Huntington's Disease, Tardive Dyskenia
    €5,439.00
  9. Bavencio (avelumab)
    Bavencio (avelumab)
    by Merck Serono Europe Limited
    for Urothelial Carcinoma, Skin Cancer
    €1,251.22
View as Grid List

Items 10-18 of 62

per page
Set Descending Direction